Rhythm Pharmaceuticals reports phase 2 PWS trial results

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Evercore ISI lowers iRhythm stock price target to $160 on valuation Hisse Senetleri 0 14
A iRhythm’s 40% decline validates InvestingPro Fair Value analysis Hisse Senetleri 0 33
A Form 8K Rhythm Pharmaceuticals Inc For: 3 April Hisse Senetleri 0 20
A Needham cuts Rhythm Pharmaceuticals stock price target on trial miss Hisse Senetleri 0 43
A Rhythm reports positive Phase 3 data for hypothalamic obesity drug Hisse Senetleri 0 24
A Form 144 iRhythm Holdings For: 24 February Hisse Senetleri 0 36
A Rhythm Pharmaceuticals stock price target raised to $130 from $120 at TD Cowen Hisse Senetleri 0 26
A Guggenheim raises Rhythm Pharmaceuticals stock price target on promising PWS data Hisse Senetleri 0 35

Benzer konular

Üst